The WasteWatcher: The Staff Blog of Citizens Against Government Waste

Pharmaceuticals

Rogue "Drug" Companies Face Congress

On Thursday, February 4, the House Committee on Oversight and Government Reform held a hearing entitled, “Developments in the Prescription Drug Market.”

Judge Tells Federal Agency to Obey the Law for Drug Discount Program

On October 14, the United States District Court for the District of Columbia struck down the Health Resources and Services Administration’s (HRSA) interpretive rule that ordered pharmaceutical manufacturers to provide substantial drug discounts under the 340B program for orphan drugs that were used off-label.  The agency had first written a proposed rule in 2011 that was in clear violation of the Affordable Care Act (ACA), better known as Obamacare, and had stubbornly fought to implement it.

More of the Same

Presidential candidate and former-Secretary of State Hillary Clinton proposed several worn-out initiatives this Tuesday that would supposedly lower drug prices but, if implemented, would seriously damage research and development in the United States while harming patients well into the future.  Many promising drugs would either never be discovered or be severely delayed in reaching the market.

Disappointing News on INNs from the FDA

You may recall I have written about the World Health Organization’s (WHO) naming system for drugs, called the International Non-Proprietary Name or INN, in a January 15, 2015 Swine Line blog and in a Citizen’s Against Government Waste August (CAGW) August 2014 WasteWatcher.  The INN was created by the WHO more than 60 years ago and its purpose was to provide an international identification system of pharmaceutical

Howard Dean is Correct

It is not too often that I agree with former Vermont Governor and Democratic presidential candidate Howard Dean but when it comes to the government “negotiating” drug prices in Medicare Part D, he is correct.

More Proof the 340B Program Needs Reform

On July 6, the Government Accountability Office (GAO), the independent, non-partisan investigative arm of Congress, released a report entitled, “Medicare Part B Drugs: Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals.”  The report confirms what Citizens Against Government Waste (CAGW) has been saying for some time; the 340B drug discount program is being abused by many hospitals for profit-making purposes and needs to be reformed.

Why is FOX Business News Pushing Price Controls?

It was the headline on the FOX Business News April 27 article that captured my attention.  It said, “More Government Waste Found at Medicare.”  I thought, well, what else is new, it’s pretty much a government-run program where waste and fraud is rampant.  The Department of Health and Human Services (HHS) estimated it was about $50 billion in 2013, about $5 billion higher than 2012.

340B Drug Discount Program Finally Gets a Congressional Hearing

On March 24, the House Energy and Commerce Subcommittee on Health held the first hearing on the 340B drug discount program since 2005.

Newt's Very Bad Idea

Former House Speaker Newt Gingrich often comes up with ideas to change how the government works.  One of his most recent suggestions has made a lot of people who care about property rights scratch their head.

Innovation = Jobs

Innovation creates jobs.

That is the central premise of Jay Walker’s keynote address, “Making Innovation Work for America and Americans,” at the first meeting of the IP Dealmakers Forum on November 6, 2014. The forum linked investors together with intellectual property (IP) information and opportunities.

Pages

Sign Up for Email Updates!Click Here!

View Archives

Posts by Author

Posts by Tag

Big Government (151) Waste (72) Obamacare (68) Budget (66) Healthcare (66) Congress (59) Uncategorized (56) Telecommunications (49) Debt (43) Technology (42) Deficit (42) Internet (41)